간행물열람

한국생체재료학회에 오신 것을 환영합니다.
home > 간행물 > 간행물열람
학회지 및 기타 간행물의 열람 제한
  • 홈페이지상에서 학회지 및 기타 간행물의 열람 및 다운로드가 가능합니다.
  • 이하의 게시물은 홈페이지의 실명으로 회원가입하신 후 학회회원임이 확인되신 경우 로그인 후 열람이 가능합니다. 궁금한 점은 생체재료학회 사무국(e-mail : ksbm2011@naver.com) 으로 문의하시기 바랍니다.
제목 [한국생체재료학회지] 제 22권 4호 303-310
작성자 관리자 등록일 2019-01-10
첨부파일

Background: Photodynamic therapy (PDT) is photo-treatment of malignant or benign diseases using photosensitizing agents, light, and oxygen which generates cytotoxic reactive oxygens and induces tumour regressions. Several photodynamic treatments have been extensively studied and the photosensitizers (PS) are key to their biological efficacy, while laser and oxygen allow to appropriate and flexible delivery for treatment of diseases. Introduction: In presence of oxygen and the specific light triggering, PS is activated from its ground state into an excited singlet state, generates reactive oxygen species (ROS) and induces apoptosis of cancer tissues. Those PS can be divided by its specific efficiency of ROS generation, absorption wavelength and chemical structure. Main body: Up to dates, several PS were approved for clinical applications or under clinical trials. Photofrin® is the first clinically approved photosensitizer for the treatment of cancer. The second generation of PS, Porfimer sodium (Photofrin®), Temoporfin (Foscan®), Motexafin lutetium, Palladium bacteriopheophorbide, Purlytin®, Verteporfin (Visudyne®), Talaporfin (Laserphyrin®) are clinically approved or under-clinical trials. Now, third generation of PS, which can dramatically improve cancer-targeting efficiency by chemical modification, nano-delivery system or antibody conjugation, are extensively studied for clinical development. Conclusion: Here, we discuss up-to-date information on FDA-approved photodynamic agents, the clinical benefits of these agents. However, PDT is still dearth for the treatment of diseases in specifically deep tissue cancer. Next generation PS will be addressed in the future for PDT. We also provide clinical unmet need for the design of new photosensitizers.
 

Key words : Photodynamic therapy, Photosensitizers, Porphyrins, Clinical trials, Clinical unmet need
 

[ 논문 다운로드]